Effect of l-arginine supplementation on insulin resistance and adipocitokines levels in head and neck cancer non diabetic patients after surgery;Efecto de la la arginina en la resistencia a la insulina y adipocitoquinas en pacientes con tumores de cabeza y cuello sin diabetes tras cirugia

Nutricion Hospitalaria

Volumn 30, Issue 4, 2014, Pages 870-875

  Luis, Daniel De ^a   Izaola, Olatz ^a   De La Fuente, Beatriz ^a   Aller, R ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adiponectin; Arginine; Head and neck cancer; Insulin resistance; Leptin

Indexed keywords

ADIPONECTIN; ARGININE; LEPTIN;

AGED; BLOOD; CONTROLLED STUDY; DIETARY SUPPLEMENT; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADIPONECTIN; AGED; ARGININE; DIETARY SUPPLEMENTS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; SINGLE-BLIND METHOD;

EID: 84908664979     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.30.4.7864     Document Type: Article

References (29)

1. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol CHem 2002;277:37487-37491.
2. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-9.
3. Shimomoura I, Hammer RE, Ikemoto S. Leptin reverses insulin resitance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73-76
4. de Luis DA, Aller R, Izaola O, Ovalle HF. The serum profile of adipokines in naïve patients with diabetes mellitus type 2 and obesity. J Clin Lab Anal 2011 ;25:409-13.
5. De Luis DA, Aller R, Romero E, Dueñas A, Perez Castrillon JL. Relation of phase angle tertiles with blood adipocytokines levels, insulin reisstance and cardiovascular risk factors in obese women patients. Eur Rev Med Pharmacol Sci. 2010 May;14(6):521-526
6. de Luis DA, Aller R, Izaola O, González Sagrado, Conde R, Perez Castrillon JL. Effects of lifestyle modification on adipocytokine levels in obese patients. Eur Rev Med Pharmacol Sci 2008;12:33-39
7. de Luis DA, Aller R, Izaola O, Conde R, Gonzalez M, González JM. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diab Res and Clin Pract 2008;79:74-78.
8. Böger RH, Ron ES. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med Rev 2005;10:14-23.
9. Lucotti P, Setola E, Monti LD, et al. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006;291:906-12
10. Hambrecht R, Hilbrich L, Erbs S, et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J am Coll Cardiol 2000;35:706-13
11. Lucotti P, Monti L, Setola E, La Canna G, Castiglioni A. Oral L arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metab Cklin and experimental 2009;58:1270-1276.
12. Di Carlo V, Gianotti I, Balzano G, Zerbi A, Braga M. Complications of pancreatic surgery and the role of perioperative nutrition. Dig Dis Sci 1999: 16: 320-326
13. De Luis DA, Izaola O, Aller R, Cuellar L, Terroba MA (2004): Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical. Eur J Clin Nutr 58:1505-1508.
14. De Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R (2009): High dose of arginine enhanced enteral nutrition in postsurgical head an neck cancer patients. A randomized clinical trial. Eur Rev Med Pharmacol Sci 2009;13:279-283.
15. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-414.
16. Picoli A, Brunani A, Savia G. Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysi. Int j Obesity 1998;22:97.
17. Kumada M, Kihara S, Noriyuki O, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109:2046-9.
18. Wascher TC, Graier WF, Dittrich P, et al. Effects of low-dose Larginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Invest 1997;27:690-5
19. Yamauchi T, Kamon J, Waki H, et al. Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis. Journal of Biological Chemistry. 2003;278:2461-2468
20. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996;19:1138-1141
21. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302:179-188
22. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein,adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83
23. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302:179-188
24. Baratta R, Amato S, Degano C, et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab. 2004;89:2665-2671
25. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85-89
26. Hattori S, Hattori Y, and Kasai K. Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism 54: 482-487, 2005.
27. Lucotti P, Setola E, Monti L, Gallucio E, Costa S, Sandoli E. Beneficial effects of a long term oral L arginine treatment addede to a hypoclaoric diet and exercices training program in obese, insulin-resistanct type 3 diabetes mellitus. AM J Physiol Endocrinol Metab 2006:906-912.
28. Casas-Rodera P., Gomez-Candela C., Benitez S Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomyzed clinical trial. Nutr Hosp 2008; 23: 105-110
29. Casas Rodera P, de Luis D A, Gomez Candela C. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a systematic review. Nutr Hosp 2012; 27: 681-90